Deborah E. Logan

Statistics

Publications

Citations

131

H-Index

Active since

1990

Affiliations

Institute of Molecular and Cell Biology(Current)

Deborah E. Logan is an author at Institute of Molecular and Cell Biology specializing in pharmacology, drug-receptor interactions, and ligand binding.

Publications per year

1990–1997

Publications

Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model.

Elizabeth M. Kudlacz, Robert W. Knippenberg, Deborah E. Logan et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 35 citations

Medicine, Immunology, Pharmacology +16

In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.

Elizabeth M. Kudlacz, Scott A. Shatzer, Robert W. Knippenberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Synthesis and structure-activity relationships for a series of substituted pyrrolidine NK1/NK2 receptor antagonists

Timothy P. Burkholder, Elizabeth M. Kudlacz, George D. Maynard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthesis and sar of 4-(1H-benzimidazole-2-carbonyl)piperidines with dual histamine H1/tachykinin NK1 receptor antagonist activity

George D. Maynard, Larry Bratton, John M. Kane et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis

Jeffrey A. Wolos, Deborah E. Logan, Terry L. Bowlin · Cellular Immunology · 1990 · 15 citations

Medicine, Pathobiology, Pharmacology +8

1–5 of 6